Erythropoietin protects retinal pigment epithelial cells from oxidative damage

Free Radical Biology and Medicine

Volumn 46, Issue 8, 2009, Pages 1032-1041

  Wang, Zhao yang ^a,b   Shen, Li jun ^a   Tu, LiLi ^a   Hu, Dan ning ^a,c   Liu, Guo Ying ^a   Zhou, Zhong lou ^a   Lin, Yi ^a   Chen, Lin Hua ^a   Qu, Jia ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Apoptosis; Erythropoietin; Free radicals; Mitochondria; Oxidant stress

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; ERYTHROPOIETIN; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; MALONALDEHYDE; PHOSPHATIDYLSERINE; PROTEIN KINASE B; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL DEATH; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PIGMENT EPITHELIUM; PRIORITY JOURNAL;

AGING; APOPTOSIS; CASPASE 3; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYTOPROTECTION; DNA DAMAGE; ERYTHROPOIETIN; HUMANS; INTERLEUKIN-1BETA; LIPID PEROXIDATION; MACULAR DEGENERATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; OLIGOPEPTIDES; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-AKT; RETINAL PIGMENT EPITHELIUM; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63049096543     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.11.027     Document Type: Article

References (73)

1. Bird A.C. The Bowman lecture: towards an understanding of age-related macular disease. Eye 17 (2003) 457-466
2. Harvey P.T. Common eye diseases of elderly people: identifying and treating causes of vision loss. Gerontology 49 (2003) 1-11
3. Hawkins B.S., Bird A., Klein R., and West S.K. Epidemiology of age-related macular degeneration. Mol. Vision 5 (1999) 26
4. Beatty S., Koh H.H., Phil M., Henson D., and Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 45 (2000) 115-134
5. Winkler B.S., Boulton M.E., Gottsch J.D., and Sternberg P. Oxidative damage and age-related macular degeneration. Mol. Vision 5 (1999) 32-43
6. Cai J., Nelson K.C., Wu M., Sternberg Jr. P., and Jones D.P. Oxidative damage and protection of the RPE. Prog. Retinal Eye Res. 19 (2000) 205-221
7. Miceli M.V., Liles M.R., and Newsome D.A. Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp. Cell Res. 214 (1994) 242-249
8. Bailey T.A., Kanuga N., Romero I.A., Greenwood J., Luther P.J., and Cheetham M.E. Oxidative stress affects the junctional integrity of retinal pigment epithelial cells. Invest. Ophthalmol. Visual Sci. 45 (2004) 675-684
9. Strunnikova N., Zhang C., Teichberg D., Cousins S.W., Baffi J., Becker K.G., and Csaky K.G. Survival of retinal pigment epithelium after exposure to prolonged oxidative injury: a detailed gene expression and cellular analysis. Invest. Ophthalmol. Visual Sci. 45 (2004) 3767-3777
10. Kannan R., Jin M., Gamulescu M.A., and Hinton D.R. Ceramide-induced apoptosis: role of catalase and hepatocyte growth factor. Free Radic. Biol. Med. 37 (2004) 166-175
11. Voloboueva L.A., Liu J., Suh J.H., Ames B.N., and Miller S.S. (R)-alpha-lipoic acid protects retinal pigment epithelial cells from oxidative damage. Invest. Ophthalmol. Visual Sci. 46 (2005) 4302-4310
12. Kasahara E., Lin L.R., Ho Y.S., and Reddy V.N. SOD2 protects against oxidation-induced apoptosis in mouse retinal pigment epithelium: implications for age-related macular degeneration. Invest. Ophthalmol. Visual Sci. 46 (2005) 3426-3434
13. Zhang C., Baffi J., Cousins S.W., and Csaky K.G. Oxidant-induced cell death in retinal pigment epithelium cells mediated through the release of apoptosis-inducing factor. J. Cell Sci. 116 (2003) 1915-1923
14. Jin G.F., Hurst J.S., and Godley B.F. Hydrogen peroxide stimulates apoptosis in cultured human retinal pigment epithelial cells. Curr. Eye Res. 22 (2001) 1.65-173
15. Sparrow J.R., and Cai B. Blue light-induced apoptosis of A2E-containing RPE: involvement of caspase-3 and protection by Bcl-2. Invest. Ophthalmol. Visual Sci. 42 (2001) 1356-1362
16. Howes K.A., Liu Y., Dunaief J.L., Milam A., Frederick J.M., Marks A., and Baehr W. Receptor for advanced glycation end products and age-related macular degeneration. Invest. Ophthalmol. Visual Sci. 45 (2004) 3713-3720
17. Del Priore L.V., Kuo Y.H., and Tezel T.H. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest. Ophthalmol. Visual Sci. 43 (2002) 3312-3318
18. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
19. Ho T.C., Yang Y.C., Cheng H.C., Wu A.C., Chen S.L., Chen H.K., and Tsao Y.P. Activation of mitogen-activated protein kinases is essential for hydrogen peroxide-induced apoptosis in retinal pigment epithelial cells. Apoptosis 11 (2006) 1899-1908
20. Yang P., Peairs J.J., Tano R., and Jaffe G.J. Oxidant-mediated Akt activation in human RPE cells. Invest. Ophthalmol. Visual Sci. 47 (2006) 4598-4606
21. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
22. Wallace D.C. Mitochondrial genetics: a paradigm for aging and degenerative diseases?. Science 256 (1992) 628-632
23. Liang F.Q., and Godley B.F. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp. Eye Res. 76 (2003) 397-403
24. Jiang X., and Wang X. Cytochrome c-mediated apoptosis. Annu. Rev. Biochem. 73 (2004) 87-106
25. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch. Ophthalmol. 119 (2001) 1417-1436
26. Lacombe C., and Mayeux P. Biology of erythropoietin. Haematologica 83 (1998) 724-732
27. Wu Y., Shang Y., Sun S., and Liu R. Antioxidant effect of erythropoietin on 1-methyl-4-phenylpyridinium-induced neurotoxicity in PC12 cells. Eur. J. Pharmacol. 564 (2007) 47-56
28. Kim K.H., Oudit G.Y., and Backx P.H. Erythropoietin protects against doxorubicin-induced cardiomyopathy via a PI3K-dependent pathway. J. Pharmacol. Exp. Ther. 324 (2008) 160-169
29. Katavetin P., Tungsanga K., Eiam-Ong S., and Nangaku M. Antioxidative effects of erythropoietin. Kidney Int. Suppl. 107 (2007) 10-15
30. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412 (2001) 641-647
31. Parsa C.J., Matsumoto A., Kim J., Riel R.U., Pascal L.S., Walton G.B., Thompson R.B., Petrofski J.A., Annex B.H., Stamler J.S., and Koch W.J. A novel protective effect of erythropoietin in the infarcted heart. J. Clin. Invest. 112 (2003) 999-1007
32. Kilic U., Kilic E., Soliz J., Bassetti C.I., Gassmann M., and Hermann D.M. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. FASEB J. 19 (2005) 249-251
33. Zhong L., Bradley J., Schubert W., Ahmed E., Adamis A.P., Shima D.T., Robinson G.S., and Ng Y.S. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Invest. Ophthalmol. Visual Sci. 48 (2007) 1212-1218
34. Tsai J.C., Wu L., Worgul B., Forbes M., and Cao J. Intravitreal administration of erythropoietin and preservation of retinal ganglion cells in an experimental rat model of glaucoma. Curr. Eye Res. 30 (2005) 1025-1031
35. Yamasaki M., Mishima H.K., Yamashita H., Kashiwagi K., Murata K., Minamoto A., and Inaba T. Neuroprotective effects of erythropoietin on glutamate and nitric oxide toxicity in primary cultured retinal ganglion cells. Brain Res. 1050 (2005) 15-26
36. Chong Z.Z., Lin S.H., Kang J.Q., and Maiese K. Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8. J. Neurosci. Res. 71 (2003) 659-669
37. García-Ramírez M., Hernández C., and Simó R. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and non-diabetic subjects. Diabetes Care 31 (2008) 1189-1194
38. 2. Free Radic. Biol. Med. 33 (2002) 691-702
39. Rollet-Labelle E., Grange M.J., Elbim C., Marquetty C., and Gougerot-Pocidalo M.A. Hydroxyl radical as a potential intracellular mediator of polymorphonuclear neutrophil apoptosis. Free Radic. Biol. Med. 24 (1998) 563-572
40. Sawyer R.T., Dobis D.R., Goldstein M., Velsor L., Maier L.A., Fontenot A.P., Silveira L., Newman L.S., and Day B.J. Beryllium-stimulated reactive oxygen species and macrophage apoptosis. Free Radic. Biol. Med. 38 (2005) 928-937
41. Tarpey M.M., Wink D.A., and Grisham M.B. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R431-R444
42. Li X., Liu Z., Luo C., Jia H., Sun L., Hou B., Shen W., Packer L., Cotman C.W., and Liu J. Lipoamide protects retinal pigment epithelial cells from oxidative stress and mitochondrial dysfunction. Free Radic. Biol. Med. 44 (2008) 1465-1474
43. Sparrow J.R., Zhou J., Ben-Shabat S., Vollmer H., Itagaki Y., and Nakanishi K. Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest. Ophthalmol. Visual Sci. 43 (2002) 1222-1227
44. Dunaief J.L., Dentchev T., Ying G.S., and Milam A.H. The role of apoptosis in age-related macular degeneration. Arch. Ophthalmol. 120 (2002) 1435-1442
45. Ambati J., Ambati B.K., Yoo S.H., Lanchulev S., and Adamis A.P. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv. Ophthalmol. 48 (2003) 257-293
46. Bressler N.M., Bressler S.B., and Fine S.L. Age-related macular degeneration. Surv. Ophthalmol. 32 (1988) 375-413
47. Godley B.F., Jin G.F., Guo Y.S., and Hurst J.S. Bcl-2 overexpression increases survival in human retinal pigment epithelial cells exposed to HO. Exp. Eye Res. 74 (2002) 663-669
48. Halliwell B., Clement M.V., and Long L.H. Hydrogen peroxide in the human body. FEBS Lett. 486 (2000) 10-13
49. 2 induce catalase and metallothionein gene expression in human retinal pigment epithelial cells. Invest. Ophthalmol. Visual Sci. 36 (1995) 1271-1279
50. Ballinger S.W., Van Houten B., Jin G.F., Conklin C.A., and Godley B.F. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp. Eye Res. 68 (1999) 765-772
51. 2 or sparfloxacin exposure. Cell. Biol. Toxicol. 16 (2000) 303-312
52. Barak A., Morse L.S., and Goldkorn T. Ceramide: a potential mediator of apoptosis in human retinal pigment epithelial cells. Invest. Ophthalmol. Visual Sci. 42 (2001) 247-254
53. Ramakrishnan R., Cheung W.K., Wacholtz M.C., Minton N., and Jusko W.J. Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J. Clin. Pharmacol. 44 (2004) 991-1002
54. Alafaci C., Salpietro F., Grasso G., Sfacteria A., Passalacqua M., Morabito A., Tripodo E., Calapai G., Buemi M., and Tomasello F. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur. J. Pharmacol. 406 (2000) 219-225
55. Chong Z.Z., Kang J.Q., and Maiese K. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106 (2002) 2973-2979
56. Watanabe D., Suzuma K., Matsui S., Kurimoto M., Kiryu J., Kita M., Suzuma I., Ohashi H., Ojima T., Murakami T., Kobayashi T., Masuda S., Nagao M., Yoshimura N., and Takagi H. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N. Engl. J. Med. 353 (2005) 782-792
57. Barouch F.C., and Miller J.W. The role of inflammation and infection in age-related macular degeneration. Int. Ophthalmol. Clin. 47 (2007) 185-197
58. BenEzra D., Hemo I., and Maftzir G. In vivo angiogenic activity of interleukins. Arch. Ophthalmol. 108 (1990) 573-576
59. Tezel T.H., Bora N.S., and Kaplan H.J. Pathogenesis of age-related macular degeneration. Trends Mol. Med. 10 (2004) 417-420
60. Chen G., Shi J.X., Hang C.H., Xie W., Liu J., and Liu X. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO). Neurosci. Lett. 425 (2007) 177-182
61. Li Y., Takemura G., Okada H., Miyata S., Maruyama R., Li L., Higuchi M., Minatoguchi S., Fujiwara T., and Fujiwara H. Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure. Cardiovasc. Res. 71 (2006) 684-694
62. Sternberg Jr. P., Davidson P.C., and Jones D.P. Protection of retinal pigment epithelium from oxidative injury by glutathione and precursors. Invest. Ophthalmol. Visual Sci. 34 (1993) 3661-3668
63. Chi O.Z., Hunter C., Liu X., and Weiss H.R. Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia. Pharmacology 82 (2008) 38-42
64. Grasso G., Sfacteria A., Meli F., Fodale V., Buemi M., and Iacopino D.G. Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain. Res. 28 (2007) 99-105
65. Martínez-Estrada O.M., Rodríguez-Millán E., González-De Vicente E., Reina M., Vilaró S., and Fabre M. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur. J. Neurosci. 18 (2003) 2538-2544
66. Zhang J., Wu Y., Jin Y., Ji F., Sinclair S.H., Luo Y., Xu G., Lu L., Dai W., Yanoff M., Li W., and Xu G.T. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest. Ophthalmol. Visual Sci. 49 (2008) 732-742
67. Bartesaghi S., Marinovich M., Corsini E., Galli C.L., and Viviani B. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 26 (2005) 923-928
68. Hanada M., Feng J., and Hemmings B.A. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim. Biophys. Acta 1697 (2004) 3-16
69. Glotin A.L., Calipel A., Brossas J.Y., Faussat A.M., Tréton J., and Mascarelli F. Sustained versus transient ERK1/2 signaling underlies the anti- and proapoptotic effects of oxidative stress in human RPE cells. Invest. Ophthalmol. Visual Sci. 47 (2006) 4614-4623
70. Li L., Takemura G., Li Y., Miyata S., Esaki M., Okada H., Kanamori H., Khai N.C., Maruyama R., Ogino A., Minatoguchi S., Fujiwara T., and Fujiwara H. Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy. Circulation 113 (2006) 535-543
71. Jin M., Yaung J., Kannan R., He S., Ryan S.J., and Hinton D.R. Hepatocyte growth factor protects RPE cells from apoptosis induced by glutathione depletion. Invest. Ophthalmol. Visual Sci. 46 (2005) 4311-4319
72. Miró O., Marrades R.M., Roca J., Sala E., Masanés F., Campistol J.M., Torregrosa J.V., Casademont J., Wagner P.D., and Cardellach F. Skeletal muscle mitochondrial function is preserved in young patients with chronic renal failure. Am. J. Kidney Dis. 39 (2002) 1025-1031
73. Pollack M., Phaneuf S., Dirks A., and Leeuwenburgh C. The role of apoptosis in the normal aging brain, skeletal muscle, and heart. Ann. N. Y. Acad. Sci. 959 (2002) 93-107